TIS 0.00% 0.0¢ tissue therapies limited

Wednesday 24, page-4

  1. 17 Posts.
    Hello all,
    I believe we will have an indication earlier than the 24th. The EMA agenda, which should appear sometime Monday afternoon, should indicate if further questions are to be adopted during this months meeting. When questions were raised during the January meeting it appeared as;

    EMEA/H/D/002831) (substance to be reviewed) insulin-like growth factor-i (igf-i) segment), (hard-to-heal wounds, primarily venous leg ulcers) • List of Questions: For adoption

    In my view, if something similar appears, the clock will again stop at 180 days and we will be again held up. If there is nothing on the agenda I hope we move on to a positive opinion. I'm unsure whether that would happen at this meeting or at the 210 day meeting in October.

    Cheers
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.